NEW YORK (GenomeWeb News) – Zygem said today that it has signed an agreement with Advalytix, a unit of Olympus Life Science Research Europe, to develop and sell a private-label line of DNA extraction products.
The partnership will combine Zygem’s enzymatic nucleic acid extraction technology with Advalytix’s expertise in single-cell molecular tests for life science research and diagnostic applications. Advalytix will market the DNA extraction products, which are designed to work with Advalytix’s single-cell molecular diagnostics and miniaturized diagnostic and biological tests for research and development.
Zygem’s technology uses a thermophilic enzyme to extract DNA from samples using a single closed-tube system. The Solana Beach, Calif.-based firm said that the technology has been validated for use in research, forensic, diagnostic, agriculture, and animal health applications.
Terms of the alliance were not disclosed.